Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
First-time investors should be aware of common mistakes that can lead to losses. Here’s what not to do for a successful start.
28,109 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
NASA plans a March liftoff for Artemis II after resolving a dangerous hydrogen leak that halted February fueling test...
Delta Air Lines posted a notable weekly gain, with delta stock 9.38% this week, even as retail social chatter turned ...
The CFPB has launched a new information request aimed at widening mortgage access, even as staffing remains tight. In...
Bitcoin is near a sensitive juncture as funding conditions tighten and equities remain richly valued. The coming week...
A high-profile Tampa real estate group is back with eXp Realty, rebranding as FIG Team Maximum Tampa and expanding it...
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
Finance America widened its lead in June as the top HECM lender, with a 23% market share and 481 endorsements for the...
XRP appears to be forming a bottom as it tests a key floor near $1.20 and eyes a breakout above $1.80, with traders w...
This article dives into Black Hills’ Q1 2026 earnings transcript, translating the numbers into actionable insights. L...